跳到正文
Citeline Podcasts(citeline.com)· Norstella·· 2 天前品質評分58

Drug Fix: US FDA Leadership Questions After Overton, AI To Be SI, Approval Doc Sharing

Drug Fix: US FDA Leadership Questions After Overton, AI To Be SI, Approval Doc Sharing

重點導讀

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the next move for the US Food and Drug Administration after Heidi Overton’s nomination for commissioner was withdrawn (1:07), as well as the impact of long-term temporary leadership (6:10) and the potential approach for the White House and Democrat-controlled Senate to find a nominee (18:01). They also consider the impact of the FDA changing references in public documents from artifici

AI 伴隨問答

自備 Key 深度分析

針對這篇報導有疑問?可直接點選快捷問題或向 AI 追問背景脈絡與技術細節:

Podcast 專家音訊節目

收錄於 888news Podcast 智庫專區,包含精華摘要與上市公司即時行情

正文

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the next move for the US Food and Drug Administration after Heidi Overton’s nomination for commissioner was withdrawn (1:07), as well as the impact of long-term temporary leadership (6:10) and the potential approach for the White House and Democrat-controlled Senate to find a nominee (18:01). They also consider the impact of the FDA changing references in public documents from artificial intelligence to super intelligence (19:20) and a new program allowing minimally redacted agency approval documents to be sent to other regulators (21:47). More On These Topics From The Pink Sheet US FDA Seeks Another Acting Commissioner With A Confirmed Head Likely In Dems’ Hands: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fda-seeks-another-acting-fda-commissioner-with-a-confirmed-head-likely-in-dems-hands-MP6CLBNZSNFKVJORGFSZBOEOJA/ White House Pulls Overton’s US FDA Commissioner Nomination Despite Cassidy Seeing Path: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/white-house-pulls-overtons-us-fda-commissioner-nomination-despite-cassidy-seeing-path-F6K3AMEH6RHOTF73ACDC3CKNEI/ Sponsors Will See ‘Super Intelligence’ On US FDA Forms, Webpages Soon, But Using ‘AI’ Still OK: https://insights.citeline.com/pink-sheet/advanced-technologies/ai/sponsors-will-see-super-intelligence-on-us-fda-forms-webpages-soon-but-using-ai-still-ok-LD22JQDOUJCLTC2PFG6YS6RWXQ/ US FDA Aims To Speed Reviews Abroad By Letting Sponsors Share Approval Packages: https://insights.citeline.com/pink-sheet/policy-regulation/us-fda-aims-to-speed-reviews-abroad-by-letting-sponsors-share-approval-packages-EPXR2I7BLRCTHJZFZQWCS52PZI/

來源: Citeline Podcasts (citeline.com)
開啟原文

讀者討論

理性交流 · 即時討論